Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Candida auris UK

ABSTRACT: Illumina paired end sequencing of Candida auris within the UK

PROVIDER: PRJEB20230 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR2299870_1.fastq.gz	Fastqsanger.gz
	ERR2299870_2.fastq.gz	Fastqsanger.gz
	ERR2299880_1.fastq.gz	Fastqsanger.gz
	ERR2299880_2.fastq.gz	Fastqsanger.gz
	ERR2299890_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 54

Similar Datasets

Haploid and Deploid for Candida auris

Project description:The expression difference for haploid and deploid of Candida auris

2020-09-13 | GSE149284 | GEO

Transcriptional Signatures Predict Phenotypic Variations of Candida auris

Project description:Transcriptomic analysis of different Candida auris clinical isolates with distinct antifungal susceptibility profiles.

2021-01-30 | GSE165762 | GEO

Candida auris whole cell proteomics

Project description:Whole cell proteomics of Candida auris MMC1 and MMC2 strains.

2019-05-24 | PXD013456 | Pride

Candida auris extracellular vesicle proteomics

Project description:Proteomic analysis of extracellular vesicles from Candida auris MMC1 and MMC2 strains.

2021-11-12 | PXD026768 | Pride

Transcriptomics and phenotyping define signatures associated with echinocandin resistance in Candida auris

Project description:Transcriptomic analysis of different Candida auris clinical isolates

2022-03-16 | GSE198410 | GEO

Overcoming amphotericin B resistance in Candida auris using the antiemetic drug, rolapitant

Project description:The emergence of Candida auris poses a significant health challenge that has led to a new era of multidrug-resistant fungal infections. Invasive infections caused by C. auris are usually associated with remarkable morbidity and mortality. For many years, amphotericin B (AmB) remained the most efficient and the last line of treatment against most hard-to-treat fungal infections. However, strains of C. auris possess extraordinary resistance to most antifungal agents, including AmB. In this study, we screened ~2600 FDA-approved drugs and clinical compounds to identify the antiemetic drug rolapitant as a promising enhancer to AmB against C. auris. Rolapitant exhibited potent synergistic interactions with AmB against all tested (29/29) C. auris isolates. In a time-kill assay, rolapitant restored the fungicidal activity of AmB within 4 h. Additionally, the synergistic relationship between rolapitant and AmB was observed against other medically crucial Candida, Cryptococcus and Aspergillus species with ΣFICI that ranged from 0.16 to 0.5. In a transcriptomic study, ion transporters and ATP generation were identified as primary pathways impacted in C. auris AR0390 cells exposed to rolapitant. An ATP luminescence assay confirmed that rolapitant, at sub-inhibitory concentrations, significantly interfered with ATP production in C. auris. Moreover, rolapitant enhanced the in vivo activity of AmB in a mouse model of disseminated C. auris infection, as the combination reduced the fungal burden in murine kidneys by ~1 log (~90%) colony forming units. Our findings warrant further investigation of using rolapitant to overcome AmB resistance in C. auris and other fungal species.

2024-09-26 | GSE263806 | GEO

Rapid in vitro evolution of flucytosine resistance in Candida auris

Project description:Comparative transcriptomic profiling of Candida auris derivative clones collected from 5FC-containing medium in comparison to the Wild-Type Strain

2024-08-22 | GSE272878 | GEO

White-Brown switching controls phenotypic plasticity and virulence of Candida auris [2]

Project description:Comparative transcriptomic profiling of Candida auris WT 1333/P/13R and CRZ2 null mutant

2025-05-30 | GSE278877 | GEO

White-Brown switching controls phenotypic plasticity and virulence of Candida auris [3]

Project description:Comparative transcriptomic profiling of Parent, White and Brown clones derived from Candida auris 1333/P/13R

2025-05-30 | GSE278878 | GEO

CO2 sensing pathway controls drug resistance and skin tropism in Candida auris

Project description:Comparative transcriptomic profiling of Candida auris RCA1 and EFG1 null mutants in comparison to the Wild-Type Strain

2025-05-30 | GSE253332 | GEO